Formoterol 12 μg

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Chronic Obstructive Pulmonary Disease

Phase 2

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

CompletedNCT01049360

AstraZenecaChronic Obstructive Pulmonary Disease

Start: 2009-12-31End: 2010-08-31Updated: 2017-02-28

Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol Fumarate

CompletedNCT01078623

AstraZenecaChronic Obstructive Pulmonary Disease

Start: 2010-02-28End: 2010-09-30Updated: 2017-02-23